Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Sep 28 · above the Ichimoku cloud · RSI 61 · MACD above its signal
None of the 29 investors followed here reported a position in TXTM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TXTM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for TXTM.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.7 | 111.5 | -13.9 | -8.5 | -1.5 | -23.4 | -18.4 | -5.0 | 42.1 | 18.5 | +88.2% | ||
| 2025 | 0.0 | -10.0 | 0.0 | -11.1 | -25.0 | 516.7 | 13.5 | -22.6 | -4.6 | -9.7 | 57.1 | -22.7 | +240.0% |
| 2024 | -5.9 | -12.5 | 21.4 | 23.5 | -57.1 | 11.1 | 10.0 | 9.1 | 58.3 | -31.6 | -7.7 | -16.7 | −41.2% |
| 2023 | -13.3 | -15.4 | -9.1 | 0.0 | 20.0 | -41.7 | 114.3 | -26.7 | -15.5 | -35.5 | 50.0 | 88.9 | +13.3% |
| 2022 | 19.3 | -22.2 | -3.8 | 52.0 | 5.3 | 460.0 | -43.7 | -33.3 | 123.8 | 34.0 | -78.2 | -45.5 | +7.1% |
| 2021 | 0.0 | 150.0 | 0.0 | 13.3 | -5.9 | 25.0 | 100.0 | -23.8 | -24.6 | -34.8 | -26.7 | 27.3 | +133.3% |
| 2020 | 0.0 | 100.0 | 0.0 | 0.0 | 50.0 | 33.3 | -12.5 | 14.3 | 0.0 | 0.0 | 50.0 | 0.0 | +500.0% |
| 2019 | 33.3 | -50.0 | 50.0 | 33.3 | -25.0 | -33.3 | 45.0 | -31.0 | -50.0 | 100.0 | 0.0 | -50.0 | −66.7% |
| 2018 | 15.4 | -33.3 | -22.0 | 15.4 | -22.2 | 0.0 | 0.0 | 0.0 | -14.3 | 0.0 | -16.7 | -40.0 | −76.9% |
| 2017 | 1125.0 | -67.3 | -18.7 | -53.8 | 65.0 | 1.0 | -20.0 | -12.5 | -14.3 | 0.0 | 0.0 | 116.7 | +225.0% |
| 2016 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 900.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 300.0 | +300.0% |
| 2015 | 900.0 | 0.0 | 0.0 | 0.0 | 900.0 | -90.0 | 0.0 | -90.0 | 900.0 | 0.0 | 0.0 | 0.0 | +900.0% |
| 2014 | 0.0 | 112.5 | -80.0 | -71.2 | -64.3 | -14.3 | -50.0 | -26.7 | -81.8 | 50.0 | -66.7 | -90.0 | −100.0% |
| 2013 | -6.2 | -20.0 | 100.0 | -66.7 | 37.5 | -18.2 | -22.2 | 0.0 | -14.3 | -83.3 | 0.0 | 0.0 | −93.8% |
| 2012 | -58.4 | -9.1 | 341.4 | -12.3 | -43.9 | -1.3 | -33.3 | -30.0 | 25.7 | -53.4 | -2.4 | -60.0 | −91.4% |
| 2011 | 0.0 | 0.0 | 0.0 | -11.1 | 5.0 | -30.5 | -31.5 | 20.0 | -33.3 | -22.5 | -12.9 | -31.5 | −83.6% |
| 2010 | 0.0 | 20.0 | 11.0 | 110.2 | -14.3 | -22.8 | -17.3 | -21.7 | -2.8 | -20.0 | -11.4 | 81.5 | +50.0% |
| 2009 | -21.2 | -12.2 | -2.2 | 25.0 | -18.2 | 22.2 | 90.9 | -4.8 | -10.0 | -12.2 | -24.1 | -37.5 | −42.3% |
| 2008 | -10.0 | -22.2 | -25.0 | 14.3 | 8.3 | 30.8 | 8.8 | -18.9 | -36.7 | -6.3 | 44.9 | 0.8 | −35.0% |
| 2007 | 51.9 | -9.8 | 8.1 | -25.0 | 6.7 | -31.3 | -9.1 | 15.0 | -6.5 | -20.9 | 11.8 | 5.3 | −25.9% |
No analyst coverage for this instrument.
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.